Study on novel treatment techniques for neurogenic gastrointestinal disorders utilizing the neuroendocrine axis and artificial intelligence technology

Research on new treatment methods for neurogenic gastrointestinal diseases based on neuroendocrine axis and artificial intelligence technology

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11239735

Enrollment

100

Registered

2024-03-05

Start date

2024-04-03

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preventing psychological illness in patients with neurogastroenteropathy Nervous System Diseases

Interventions

Objective: To investigate the efficacy of physical music therapy on psychological well-being compared to a control group without intervention. Participants: Participants will be divided into two grou

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Free from genetic diseases 2. Patients with neural digestive disease, with no mental illness 3. Patients with IBS-D

Exclusion criteria

Exclusion criteria: Diseases with obvious abnormalities in the auditory system

Design outcomes

Primary

Measure	Time frame
Pain and related symptoms in irritable bowel syndrome (IBS) measured using the IBS-Symptom Severity Scale (IBS-SSS) from baseline monthly up to 6 months	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

China

Contacts

Public ContactQin Yi Qin

2116228604@qq.com+86 13384768595

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026